Outlook Therapeutics, Inc. - Common Stock (OTLK)
1.6900
-0.0200 (-1.17%)
Outlook Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative treatments for eye diseases
The company specializes in the research and advancement of therapies aimed at addressing significant unmet medical needs in ophthalmology. Through its proprietary drug pipeline, Outlook Therapeutics is committed to enhancing the quality of life for patients affected by various retinal conditions, striving to bring new possibilities and improved outcomes to vision care.
Frequently Asked Questions
Is Outlook Therapeutics, Inc. - Common Stock publicly traded?
Yes, Outlook Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Outlook Therapeutics, Inc. - Common Stock trade on?
Outlook Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Outlook Therapeutics, Inc. - Common Stock?
The ticker symbol for Outlook Therapeutics, Inc. - Common Stock is OTLK on the Nasdaq Stock Market
What is the current price of Outlook Therapeutics, Inc. - Common Stock?
The current price of Outlook Therapeutics, Inc. - Common Stock is 1.690
When was Outlook Therapeutics, Inc. - Common Stock last traded?
The last trade of Outlook Therapeutics, Inc. - Common Stock was at 4:00 pm EST on February 10th, 2025
What is the market capitalization of Outlook Therapeutics, Inc. - Common Stock?
The market capitalization of Outlook Therapeutics, Inc. - Common Stock is 40.40M
How many shares of Outlook Therapeutics, Inc. - Common Stock are outstanding?
Outlook Therapeutics, Inc. - Common Stock has 23.91M shares outstanding.